Annual Total Expenses
$77.15 M
+$1.95 M+2.59%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual total expenses is currently $77.15 million, with the most recent change of +$1.95 million (+2.59%) on 31 December 2023. ZBIO annual total expenses is now at all-time high.ZBIO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$40.98 M
+$1.28 M+3.23%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly total expenses is currently $40.98 million, with the most recent change of +$1.28 million (+3.23%) on 30 September 2024. Over the past year, it has increased by +$16.20 million (+65.40%). ZBIO quarterly total expenses is now at all-time high.ZBIO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +65.4% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2.6% | at high | +185.1% |
| 5 y | 5 years | at high | +2.6% | at high | +185.1% |
| alltime | all time | at high | +2.6% | at high | +185.1% |
ProShares UltraPro Short Nasdaq Biotechnology Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.98 M(+3.2%) |
| June 2024 | - | $39.70 M(+44.0%) |
| Mar 2024 | - | $27.58 M(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $77.15 M(+2.6%) | $24.78 M(+72.4%) |
| Sept 2023 | - | $14.38 M |
| Dec 2022 | $75.20 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual total expenses?
- What is the all time high annual total expenses for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total expenses?
- What is the all time high quarterly total expenses for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total expenses year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual total expenses?
The current annual total expenses of ZBIO is $77.15 M
What is the all time high annual total expenses for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual total expenses is $77.15 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total expenses?
The current quarterly total expenses of ZBIO is $40.98 M
What is the all time high quarterly total expenses for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly total expenses is $40.98 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total expenses year-on-year change?
Over the past year, ZBIO quarterly total expenses has changed by +$16.20 M (+65.40%)